TLDR
-
HIVE stock fell 10.64% to $3.70 after the $100 million notes plan announcement.
-
The 2031 notes carry no regular interest and may convert into HIVE common shares.
-
HIVE plans to spend the proceeds on GPUs, data centers, and corporate needs.
-
An extra $15 million option could increase the total offering to $115 million.
-
Capped call deals aim to reduce dilution and offset exchange-related costs.
HIVE Digital Technologies (HIVE) shares fell 10.64% to $3.70 intraday after the company announced a major financing plan. The $100 million notes offering introduces potential dilution through future exchanges into HIVE common shares. HIVE plans to use the proceeds for corporate spending, graphics processors, and data center development.
HIVE Digital Technologies Ltd., HIVE
HIVE Plans Zero-Interest Notes Offering
HIVE said its Bermuda-based subsidiary plans to sell $100 million of exchangeable senior notes due in 2031. The private offering will target qualified institutional buyers under Rule 144A of the Securities Act. Initial purchasers may also buy another $15 million of notes within 13 days after issuance.
The notes will carry no regular interest, and their principal value will not increase over time. HIVE will guarantee the subsidiary’s obligations on a senior unsecured basis. The issuer will determine the initial exchange rate and final terms when it prices the offering.
The issuer may settle exchanges with cash, HIVE common shares, or a combination of both. That structure gives HIVE flexibility, but it also creates potential share dilution. The announcement coincided with immediate pressure on HIVE stock during the trading session.
Proceeds Target GPUs and Data Centers
HIVE plans to channel the offering proceeds into one or more direct or indirect subsidiaries. Those units will use the funds for general corporate purposes and capital investments. Planned spending includes graphics processing units and further data center development.
The company may also use part of the proceeds to cover costs connected with the capped call arrangements. HIVE expects to fund those transactions initially with cash already held. The issuer could reimburse HIVE after completing the notes sale.
Additional note sales would provide more funding if initial purchasers exercise the $15 million option. HIVE could direct those proceeds toward similar corporate and development expenses. The company may also arrange extra capped call transactions for the additional notes.
Capped Calls Aim to Limit Dilution
HIVE expects to enter cash-settled capped call transactions with several financial institutions. These contracts will cover the common shares initially underlying the exchangeable notes. The company designed the structure to reduce economic dilution when noteholders exchange their securities.
The transactions could also offset cash payments above the notes’ principal amount. However, the protection will apply only up to a defined cap. HIVE may arrange additional capped calls if purchasers take the full optional allocation.
Financial institutions may buy HIVE shares or use derivatives while establishing their initial hedges. They may later adjust those positions through further purchases, sales, or derivative trades. HIVE said such activity could affect its share price before maturity or during exchange observation periods.
🚨 Our JUNE Stock Picks Are Live!
A new month means new opportunities. Our analysts have just released their top stock picks for June, highlighting companies with strong momentum that rank highly on our KO Score algorithm. We’re also now sharing trade ideas for both long-term and short-term investors, giving you more ways to spot potential opportunities in the market.
Sign up to Knockout Stocks today and get 50% off to unlock the full list and see which stocks made the cut.
Use coupon code Special50 for your exclusive discount!







